A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial
This study is testing a special way to deliver chemotherapy directly to the liver using a small pump, alongside standard chemotherapy. Doctors want to see if this targeted approach works better at shrinking liver tumors from colon or rectum cancer than standard chemotherapy alone.
You may be able to join if you are 18 or older and have colon or rectum cancer that has spread to the liver and cannot be removed by surgery. The cancer should mostly be in the liver, though very small, stable lung spots may be allowed.
Participants will be randomly assigned to receive either standard chemotherapy alone or standard chemotherapy combined with a pump that delivers medicine straight into the liver. You will also have regular check-ups, imaging scans, and safety monitoring throughout the study.
This study is currently recruiting patients at medical centers in locations including Alabama and Arizona. Your care team will let you know if a participating hospital is convenient for you.
- 1Tests direct chemotherapy delivery to liver tumors using a specialized pump.
- 2Compares pump treatment plus standard care against standard care alone.
- 3Currently recruiting participants at select hospitals in the United States.
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.